Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers | MicrobiomeTrials← Back to trialsNCT06562192
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-10-15Est. Completion: 2031-01-15
Enrollment target: 162 participants Locations- Uni of Alabama at Birmingham, Birmingham, Alabama, United States
- University of California LA, Los Angeles, California, United States
- Stanford University Medical Center, Palo Alto, California, United States
- Mayo Clinic Jacksonville, Jacksonville, Florida, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- BAMF Health, Grand Rapids, Michigan, United States
- Mayo Clinic Rochester, Rochester, Minnesota, United States
- Uni Of TX MD Anderson Cancer Cntr, Houston, Texas, United States
- University Of Washington, Seattle, Washington, United States
- Novartis Investigative Site, Brussels, Belgium
- Novartis Investigative Site, Toronto, Ontario, Canada
- Novartis Investigative Site, Montreal, Quebec, Canada
- Novartis Investigative Site, Montreal, Quebec, Canada
- Novartis Investigative Site, Bron, France
- Novartis Investigative Site, Villejuif, France
- Novartis Investigative Site, Cologne, North Rhine-Westphalia, Germany
- Novartis Investigative Site, Essen, Germany
Other microbiome trials you might be interested in
Pancreatic CancerPancreatic Cancer MetastaticPDACPDAC - Pancreatic Ductal AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Adenocarcinoma
The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compar…
Phoenix, United StatesEst. completion Jun 2028
Novartis Investigative Site, München, GermanyNovartis Investigative Site, Rostock, GermanyNovartis Investigative Site, Tel Aviv, IsraelNovartis Investigative Site, Milan, MI, ItalyNovartis Investigative Site, Reggio Emilia, RE, ItalyNovartis Investigative Site, Nijmegen, Gelderland, NetherlandsNovartis Investigative Site, Utrecht, NetherlandsNovartis Investigative Site, Barcelona, SpainNovartis Investigative Site, Madrid, SpainNovartis Investigative Site, Madrid, SpainNovartis Investigative Site, Geneva, SwitzerlandNovartis Investigative Site, Lausanne, SwitzerlandGlioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
The goal of this Phase I clinical trial is to evaluate how the imaging drug 203Pb- RMX-VH-PIB distributes in the body an…
Houston, United StatesEst. completion Dec 31, 2026